Evaluation of White Sweet Potato Tube Feeding Formula on Type 2 Diabetic Residents in Long-term Care Institutions
- Conditions
- Type 2 Diabetes
- Interventions
- Dietary Supplement: White sweet potato formulaDietary Supplement: Commercial diabetic formula
- Registration Number
- NCT02711839
- Lead Sponsor
- Taipei Medical University
- Brief Summary
In order to response the increasing of aging population cause losing ability that need long-care needs, the project entitled "10-year long-term care program" from Executive Yuan in 2007 is carried out to assist economically disadvantaged and disabled elderly to acquire daily nutrition. Therefore, the long-term care resident's nutritional status got more attention than before. Out of control in blood glucose will not only increase bed sores and urinary tract infection in tube feeding residents but also rise medical expenditures. The nutritional status of long-term care institutions, anyang homes and nursing home are generally bad in nutrition management due to high cost of nutritional supplements from foreign imports that cause the burden of families. In this study, we will recruit diabetic subjects that divide into white sweet potato group (experimental group) and commercial formula group (control group) by using randomized, parallel and open clinical study through tube feeding in sixty days.
- Detailed Description
All subjects will be evaluated the blood sugar and clinical nutrition assessment such as postural measurement, urine test and blood biomarker examination.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 54
- Long-term stability nasogastric or gastrostomy-fed person.
- The physician diagnosed as diabetic and regular use of hypoglycemic drugs.
- Psychosis or depression.
- Hba1c> 8.5%.
- High taking nutritional supplements or steroids drugs.
- Have undergone abdominal surgery caused by intestinal sticky.
- Suffering from cancer, ulcers, respiratory infections and other diseases.
- Currently receiving central venous nutrition therapy or intravenous nutrition therapy.
- Liver dysfunction (ALT ≧ 100 U / L), renal insufficiency (creatinine ≧ 3mg / dl), heart failure (NYFc II above), moderate anemia (hemoglobin <9 g / dl).
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Treatment Group White sweet potato formula White sweet potato formula Control Group Commercial diabetic formula Commercial diabetic formula
- Primary Outcome Measures
Name Time Method HbA1c After Intervention 60 days HbA1c value after 60 days intervention in both groups
- Secondary Outcome Measures
Name Time Method Albumin After Intervention 60 days Albumin value after 60 days intervention in both groups
Glucose After Intervention 60 days Glucose value after 60 days intervention in both groups
Total Cholesterol After Intervention 60 days Total cholesterol value after 60 days intervention in both groups
Triglyceride After Intervention 60 days Triglyceride value after 60 days intervention in both groups